(Abstracted from J Urol 2017;198:890–896)
Primary treatment approaches for women with urgency urinary incontinence (UUI) include medications and behavioral therapy. Patients with UUI refractory to primary treatments may be offered third-line treatment options such as sacral neuromodulation (SNM) or onabotulinumtoxinA.
University of Alabama at Birmingham, Birmingham, AL (H.E.R.); Duke University, Durham (C.L.A.); RTI International, Research Triangle Park (S.W.E., D.W.), NC; Cleveland Clinic, Cleveland, OH (J.E.J.); University of New Mexico, Albuquerque, NM (Y.K.); Magee-Women's Research Institute, University of Pittsburgh, Pittsburgh (C.C.); University of Pennsylvania, Philadelphia (H.S.H.), PA; University of California–San Diego, San Diego, CA (M.A.); Brown University, Providence, RI (D.M.); and Oregon Health and Science University, Portland, OR (W.T.G.)